선택적 COX-2 저해를 통한 구강암세포주KB의 침습성 변화에 관한 예비연구
Change of the invasiveness with selective COX-2 inhibition in an oral squamous cell carcinoma cell line, KB ; preliminary in vitro study
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Abstract
Cyclooxygenase-2 (Cox-2) is known as one of the critical factor in carcinomas of various organs. However, the importance of Cox-2 in oral squamous cell carcinoma has not been fully described yet. The purpose of this study is to evaluate the anti-cancer effect of selective cox-2 inhibitor, celecoxib in an oral squamous cell carcinoma cell line, KB with respect to cytotoxicity test, in vitro invasion and MMP-2 expression. In cytotoxicity test, celecoxib treated group showed definitely concentration dependent cytotoxicity. In addition, administration of celecoxib reduced the invasive potential of KB cell line significantly in invasion assay. However, there was no remarkable difference of the MMP-2 expression between the celecoxib treated group and the control group. Considering these data, celecoxib had a potential cytotoxic agent to oral squamous cell carcinoma cells. Also, it had anti-invasive property without acting on the MMP-2 expression mechanism. Therefore, it was postulated that celecoxib had the possibility of anti-cancer agent in treatment strategies of oral squamous cell carcinoma.
참고문헌 (17)
- "The effect of nitric oxide on cyclooxygenase-2 (COX-2) overexpression in head and neck cancer cell lines", 107, pp.729~738 (2003)
- "Modulation of cyclooxygenase-2 activities by the combined action of celecoxib and decosahexaenoic acid: novel strategies for colon cancer prevention and treatment", 3, pp.215~221 (2004)
- "Chemopreventive effect of JTE-522, a selective cyclooxygenase-2 inhibitor, on 1, 2-dimethylhydrazine-induced rat colon carcinogenesis", 202, pp.11~16 (2003)
- "15-Lipoxygenase-1 mediates cyclooxygenase-2 inhibitorinduced apoptosis in gastric cancer", 24, pp.243~247 (2003)
- "Evaluation of a selective prostaglandin E receptor EP1 antagonist for potential properties in colon carcinogenesis", 21, pp.3865~3869 (2001)
- "a potent cyclooxygenase-2 inhibitor in cancer prevention", 28, pp.127~142 (2004)
- "Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice", 109, pp.576~580 (2004)
- "Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of", 64, pp.1181~1189 (2004)
- "Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis", 21, pp.3425~3432 (2001)
- "A COX-2 inhibitor, nimesulide, inhibits chemicallyinduced rat tongue carcinogenesis through suppression of cell proliferation activity and COX-2 and iNOS expression", 18, pp.39~48 (2003)
- "A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters", 104, pp.269~273 (2003)
- "Piroxicam is an ineffective inhibitor of N-nitrosomethylbenzylamine-induced tumorigenesis in the rat esophagus", 62, pp.4376~4382 (2002)
- "Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptorgamma (Review)", 20, pp.1109~1122 (2002)
- "Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett’s esophagus", 122, pp.1101~1112 (2002)
- "Loss of nuclear p27 (CDKN1B", KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP, 2007, pp.20, 15~22
- "Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression", 17, pp.1625~1630 (2006)
- "Therapeutic potential of selective cyclooxygenase-2 inhibitors in the management of tumor angiogenesis", 37, pp.179~192 (2003)
